Tissue specificity: The clinical importance of steroid metabolites in hormone replacement therapy

Maturitas

Volumn 37, Issue 3, 2001, Pages 151-157

  Gruber, Doris M ^a   Huber, Johannes C ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Androgen; Estrogen; Hormone replacement therapy; Metabolite replacement therapy; Progesterone

Indexed keywords

LIOTHYRONINE; STEROID HORMONE; THYROXINE;

ADAPTATION; BODY COMPOSITION; HORMONE ACTION; HORMONE DEFICIENCY; HORMONE RELEASE; HORMONE SUBSTITUTION; HUMAN; METABOLIC ACTIVATION; RECEPTOR BINDING; REVIEW; SUBSTITUTION THERAPY; THYROID FUNCTION; TISSUE SPECIFICITY;

EID: 0035977586     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(00)00169-9     Document Type: Article

References (40)

1. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism
2. Recurrent secretion of progesterone in large amounts: An endocrine/metabolic disorder unique to young women?
3. In vivo aspects of progesterone distribution and metabolism
4. Production rates and metabolism of sulphates of 3β-hydroxy-5α-pregnane derivatives in pregnant women
5. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor
6. Progesterone metabolite allopregnanolone in women with premenstrual syndrome
7. Structure-activity relationships for steroid interaction with the gamma-aminobutyric acid receptor complex
8. Circulating levels of anxiolytic steroids in the luteal phase in women with premenstrual syndrome and in control subjects
9. Biosynthesis and assay of neurosteroid in rats and mice: Functional correlates
10. Interaction of oestrogen and physiological progesterone metabolites in the control of gonadotropin secretion
11. Inhibition of oxytocin receptor function by direct binding of progesterone
12. Progesterone metabolite and spontaneous myometrial contractions in vitro
13. Visceral obesity: A 'civilisation syndrome'
14. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion
15. Metabolic clearance rates of androgens and oestrogens in ageing women
16. Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause
17. The effects of testosterone treatment on body composition and metabolism in middle-aged obese men
18. Exogenous androgens influence body composition and regional body fat distribution in obese postmenopausal women - A clinical research center study
19. The effects of androgens on the regulation of lipolysis in adipose precursor cells
20. The effect of percutaneous androgen replacement therapy on body composition and body weight in postmenopausal women
21. Dihydrotestosterone, stanozolo, androstenedione and dehydroepinadrosterone sulphate inhibit leptin secretion in female but not in male samples of omental adipose tissue in vitro: Lack of effect of testosterone
22. Dihydrotestosterone exerts a depressive influence on the production of interleukin-4 (IL-4), IL-5, and gamma-interferon, but not IL-2 by activated murine T cells
23. Effect of 5-alpha dihydrotestosterone on T-cell proliferation of the female nonobese diabetic mouse
24. Androgen influence on lacrimal gland apoptosis, necrosis, and lymphocytic infiltration
25. Physiological importance of dehydroepiandrosterone
26. Biologic activity of dehydroepinadrosterone sulfate in man
27. 5-androstene-3β,17β-diol with estradiol and dihydrotestosterone receptors in human myometrial and mammary cancer tissue
28. Estrogenic effects of 5-androstene-3β,17β-diol at physiological concentrations and its possible implication in the etiology of breast cancer
29. The age of dehydroepiandrosterone
30. Molecular origin of cancer: Catechol estrogen-3,4-quinones as endogenous tumor initiators
31. New role for estrogen in cancer
32. Biological properties of 16α-hydroxyestrone: Implications in estrogen physiology and pathophysiology
33. Abnormal oxidative metabolism of estradiol in women with breast cancer
34. The effect of a low fat diet on estrogen metabolism
35. Effects of obesity on estradiol metabolism: Decreased formation of nonuterotropic metabolites
36. Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking
37. The endogenous oestrogen metabolite 2-methoxyestradiol inhibits angiogenesis and suppresses tumor growth
38. 2-Methoxyestradiol-induced phosphorylation of Bcl-2: Uncoupling from JNK/SAPK activation